Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 156 entries
View as:

A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1

Phase: N/A Priority: Normal
NCT ID: NCT06961266 Org: User:
Start: 05/13/25 End: 04/01/26 Due: 04/01/27

Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04421456 Org: User:
Start: 08/18/20 End: 03/16/22 Due: 03/16/23

Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00361842 Org: User:
Start: 07/31/06 End: 12/31/08 Due: 12/31/09

Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00389428 Org: User:
Start: 09/30/06 End: 12/31/09 Due: 12/31/10

Investigation of Cognitive Outcomes With Cannabidiol Oral Solution

Phase: N/A Priority: Normal
NCT ID: NCT04133480 Org: User:
Start: 10/31/20 End: 12/31/21 Due: 12/31/22

A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)

Phase: N/A Priority: Normal
NCT ID: NCT02257684 Org: User:
Start: 09/30/14 End: 01/31/16 Due: 01/31/17

A Safety and Efficacy Study of Xyrem® in Subjects With Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT00371137 Org: User:
Start: 08/31/06 End: 12/31/08 Due: 12/31/09

A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

Phase: N/A Priority: Normal
NCT ID: NCT05152147 Org: User:
Start: 12/02/21 End: 05/15/26 Due: 05/15/27

A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex

Phase: N/A Priority: Normal
NCT ID: NCT05864846 Org: User:
Start: 06/29/23 End: 03/26/26 Due: 03/26/27

An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients

Phase: N/A Priority: Normal
NCT ID: NCT02238925 Org: User:
Start: 07/31/14 End: 01/31/16 Due: 01/31/17

Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT00087555 Org: User:
Start: 07/31/04 End: 01/31/06 Due: 01/31/07

Abuse Potential of Sativex

Phase: N/A Priority: Normal
NCT ID: NCT01323569 Org: User:
Start: 02/29/08 End: 06/30/08 Due: 06/30/09

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06695845 Org: User:
Start: 01/14/25 End: 12/31/27 Due: 12/31/28

Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00358501 Org: User:
Start: 07/31/06 End: 03/31/15 Due: 03/31/16

A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01599234 Org: User:
Start: 03/31/05 End: 12/31/05 Due: 12/31/06

A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351

Phase: N/A Priority: Normal
NCT ID: NCT03555955 Org: User:
Start: 11/20/18 End: 05/26/21 Due: 05/26/22

"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"

Phase: N/A Priority: Normal
NCT ID: NCT02348606 Org: User:
Start: 05/31/15 End: 12/31/16 Due: 12/31/17

A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

Phase: N/A Priority: Normal
NCT ID: NCT03030599 Org: User:
Start: 03/14/17 End: 07/10/19 Due: 07/10/20

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06108050 Org: User:
Start: 11/07/23 End: 05/31/28 Due: 05/31/29

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06435429 Org: User:
Start: 08/13/24 End: 11/26/31 Due: 11/26/32

An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01610700 Org: User:
Start: 05/31/01 End: 07/31/02 Due: 07/31/03

Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Phase: N/A Priority: Normal
NCT ID: NCT01337089 Org: User:
Start: 01/19/11 End: 01/27/16 Due: 01/27/17

A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy

Phase: N/A Priority: Normal
NCT ID: NCT01681121 Org: User:
Start: 09/30/12 End: 08/31/13 Due: 08/31/14

Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting

Phase: N/A Priority: Normal
NCT ID: NCT05772429 Org: User:
Start: 04/17/23 End: 07/31/26 Due: 07/31/27

An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT02607904 Org: User:
Start: 12/15/16 End: 05/27/19 Due: 05/27/20